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The impact of lymphoedema on a patient’s quality of life (QoL) has generally been underestimated. 
However, it is now clear that it can 
cause physical symptoms, impaired 
physical and social function and 
emotional effects (Moffatt et al, 2003).
A number of attempts have been 
made to define QoL (Higginson and 
Carr, 2001) and it is a very personal 
issue. However, in healthcare it usually 
incorporates physical and social health 
and functioning and psychological and 
emotional wellbeing (Bowling, 1997).
Study 36-item short form (SF-36) 
(Ware and Sherbourne, 1992), which 
assesses functional health status, or 
‘condition-specific’, e.g. European 
Organisation for Research and 
Treatment of Cancer Quality of Life 
Questionnaire – Core 30 questions 
(EORTC QLQ-C30) (Aaronson et al, 
1993) and QLQ-BR23, a 23-question 
tool specifically for breast cancer 
(Sprangers et al, 1996). However, 
general health-related measures may 
not be as accurate or informative as 
condition-specific tools (Morgan et al, 
2005).
In the recent literature, a number of 
lymphoedema/chronic oedema-specific 
QoL assessment tools have been 
reported. For some, the validation has 
been published, e.g. ULL-27 for upper 
limb lymphoedema (Launois and Alliott, 
2000) and FLQA-L for lymphoedema 
of arms and legs (Augustin et al, 2005). 
For others, the tools have been used 
in studies without a formal validation 
being reported, e.g. Wesley Clinic 
Lymphoedema Scale (WCLS) or post 
mastectomy lymphoedema (Mirolo 
et al, 1995) and an un-named tool for 
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Background: This paper describes the validation of a ‘condition-specific’ quality of life (QoL) assessment tool for 
lymphoedema of the limbs (LYMQOL). Aims: To ascertain whether the tool could accurately assess QoL in this patient 
group. Methods: Face and content validity were assessed by patient questionnaires; criterion validity by comparison with 
European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire – Core 30 questions (EORTC 
QLQ-C30); internal validity by Cronbach’s Alpha and split half-testing of each domain; reliability by the test-retest method; 
construct validity by comparing LYMQOL score with initial limb volume and responsiveness by measuring changes in score 
following treatment. Results: The tool was validated in a total of 209 patients. Face, content, criterion and internal validity 
were supported.  However, there was no correlation between initial limb volume and LYMQOL score (construct validity), 
a finding which is similar to that from other studies.  The validation of responsiveness was limited by the small numbers of 
responses at three and six months after the initial assessment. Conclusions: LYMQOL is a validated condition-specific QoL 
assessment tool which can be used for lymphoedema of the limbs both in clinical assessment and as an outcome measure. 
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This paper describes the 
validation of a condition-
specific QoL measure for 
lymphoedema of the limbs 
(LYMQOL) which could be 
used routinely in clinical 
services.
QoL measures can be used to assess 
the impact of chronic oedema on the 
individual and also to demonstrate 
changes as a result of treatment (Keeley, 
2008). They can be used as practical 
clinical tools influencing treatment 
decisions and measuring outcome, as 
well as in research studies assessing the 
effectiveness and cost-effectiveness of 
interventions (Higginson and Carr, 2001).
Health-related quality of life 
measures that have been used in 
studies of lymphoedema have been 
either ‘general’, e.g. Medical Outcome 
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peripheral lymphoedema (Weiss and 
Spray, 2002).
This paper describes the validation 
of a condition-specific QoL measure for 
lymphoedema of the limbs (LYMQOL) 
which could be used routinely in clinical 
services. Interim stages of the validation 
process have been previously reported 
(Keeley et al, 2004).
Methods
Development of the tool
LYMQOL was developed by 
experienced healthcare professionals 
in the lymphoedema service in Derby, 
UK in consultation with service users. 
Separate tools were developed for 
arm and leg lymphoedema. The tools 
were designed as patient-completed 
questionnaires with a structure similar 
to the EORTC QLQ-C30 (Appendices 
1a and 1b).
The questions cover four domains:
8 Symptoms
8 Body image/appearance
8 Function
8 Mood.
There is an overall QoL rating. The 
mood questions were taken from the 
previously validated EORTC QLQ-C30 
with permission.
Scoring of LYMQOL
Each item in each domain was scored:
8 Not at all = 1
8 A little  = 2
8 Quite a bit = 3
8 A lot  = 4.
A total score for each domain was 
calculated by adding all scores together 
and dividing by the total number of 
questions answered. If fewer than 50% 
of the items were answered, the whole 
domain was scored as 0. The ‘overall 
QoL’ item was scored 0–10.
In some of the analyses, the domain 
scores were calculated as a percentage 
to facilitate comparison with other 
measures (see below).
Validation
The study was designed to measure 
(Fallowfield, 1990): 
8 Validity, i.e. is the scale measuring 
what it was designed to do?
8 Reliability, i.e. to what extent can the 
scale be reproduced under different 
conditions? 
8 Responsiveness, i.e. is the scale 
sensitive enough to record significant 
changes following treatment?
Specific aspects of these elements 
were measured as follows.
Face validity
The subjective assessment of the 
presentation of the questionnaire and 
its relevance was measured using a 
short questionnaire that was given to 
patients who took part in the study 
(Appendix 2).
Content validity: does the content address all the 
important issues
This was assessed from the patient 
questionnaire and by a separate study 
(Veigas and Keeley, 2004). The study 
was a phenomenological interview 
of 22 patients. The main themes that 
emerged were loss, both actual and 
potential, relating to the individual’s 
role, work, body image, self-esteem 
and embarrassment. 
Criterion validity: how does the new measure 
compare with a ‘gold standard’ tool?
No such condition-specific tool was 
available at the time the study was 
carried out. Therefore, the results 
were compared with relevant sections 
of the EORTC QLQ-C30 in the first 
50 patients, using the Spearman or 
Pearson correlation coefficient and 
intra-class correlation coefficient. 
Internal validity
This includes:
8 Internal consistency: by Cronbach’s 
Alpha and split half-testing of 
each domain. The latter tests 
for homogeneity, i.e. the extent 
to which the questions relating 
to a particular domain measure 
only that and no other. Split half-
testing was carried out in two 
ways, the first comparing first 
and second half items and the 
second comparing odd and even 
numbered items. The Spearman-
Brown coefficient was used to test 
for similarities between the two 
halves
8 Reliability: by the test re-test 
method in a subgroup of patients. 
The first measure was carried 
out at the initial assessment and 
the second before intensive 
treatment with bandaging, i.e. 
repeated in individual patients 
before any treatment had been 
given, and therefore it was unlikely 
that there would have been any 
significant change in QoL. Results 
were compared using Pearson’s 
correlation coefficient. 
Construct validity: to what extent does the tool 
test the theory it is measuring?
It was postulated that patients with 
more severe lymphoedema (i.e. larger 
limb volumes) would have a ‘lower’ 
QoL, i.e. higher scores in LYMQOL 
domains. Therefore, initial limb volume 
was compared with LYMQOL scores 
in each domain, using the paired  
T test.
Responsiveness: is the tool sensitive to change?
This was assessed by measuring 
changes in QoL scores following 
treatment, using the Pearson 
correlation coefficient.
Inclusion criteria:
8 New patients presenting to the 
lymphoedema clinic in Derby who 
consented to take part
8 Patients over 18 years of age with 
unilateral or bilateral swelling of 
upper or lower limbs.
Exclusion criteria:
8 Those with active malignancy
8 Those undergoing chemotherapy.
Data was collected as follows:
8 First visit:
 l	demographics, i.e. gender, age,
 l	site of lymphoedema, cause 
 of lymphoedema
 l	LYMQOL score
 l	Patient questionnaire
 l	EORTC QLQ-C30 (first 50   
 patients)
 l	Limb volume measurement.
8 Follow-up at one week, one 
month, three months and six 
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months after treatment either 
with a compression garment or 
multilayer lymphoedema bandaging 
± manual lymphatic drainage 
(MLD). This involved:
 l	LYMQOL score
 l	Limb volume measurement.
The study was approved by the 
Southern Derbyshire Local Research 
Ethics Committee (Reference No: 
SDLREC 0202/438).
Results
A total of 209 patients took part 
in the study, of which 78.7% were 
women. The mean age of participants 
was 58 years (SD 16.4 years). Bilateral 
leg swelling was the most frequently 
reported site of swelling (43.8%). 
Approximately one quarter of the 
sample reported unilateral arm swelling 
(26.8%) or unilateral leg swelling 
(27.7%). 1.5% of patients reported that 
a combination of arms and legs was 
swollen.
Face validity
Face validity was confirmed (Table 1). 
Patients found LYMQOL clear, easy to 
complete and not too long.
Content validity
There were 90 patient questionnaires 
returned. Although 92% of respondents 
felt that no questions could be left out, 
20% felt that there were important 
areas missing. The main themes of these 
are shown in Table 2.
Criterion validity
The LYMQOL results for the domains 
‘function’, ‘symptoms’, ‘mood’ and ‘overall 
QoL’ showed good correlation with 
those for comparable domains in the 
EOTC QLQ-C30 for both arm and 
leg questionnaires (Tables 3 and 4). 
There was no comparable domain 
in the EORTC QLQ-C30 for that 
of ‘appearance’ in LYMQOL, so no 
comparison could be made.
Internal validity
Internal consistency — Cronbach’s alpha
Cronbach’s alpha was >0.8 for all 
domains in both the arm and leg 
versions of LYMQOL, thus confirming 
internal consistency (Tables 5 and 6).
Deleting any of the items did not 
appear to increase the value of alpha 
by a large amount, i.e. did not improve 
internal consistency and therefore 
supported the reliability.
The small number in the ‘symptom’ 
domains included in the analysis 
reflects the relatively large number of 
incomplete responses in this domain.
Split half-testing of each domain
Reliability was adequate (≥0.8) or 
good (≥0.9) for each of the domains 
with the exception of ‘symptoms’ 
for LYMQOL (arm) when first and 
second halves were compared (Tables 
7 and 8). This is likely to be because 
the questions in the first half are all 
part of Q11 and relate to the site and 
degree of pain. The second method of 
testing is therefore more appropriate 
for this domain. Reliability was found 
to be adequate or good for all of the 
domains tested.
Reliability
Reliability was supported using the 
test-retest method for 15 patients who 
had leg oedema (Table 9). This number 
is relatively small and reflects the fact 
that most patients were treated at the 
first clinic appointment and the test-
retest method could only be used in 
those who returned for treatment at 
a later date. Nevertheless, there was 
good correlation between the mean 
scores for each domain at visit one and 
two, i.e. with no intervening treatment 
in this subgroup.
Construct validity
It was postulated that patients with 
more severe swelling, i.e. larger limb 
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volume would have a ‘lower’ quality of 
life. Therefore, LYMQOL scores were 
compared with initial limb volume.
There was no significant correlation 
between any of the domains of 
LYMQOL and the initial limb volume.
Responsiveness
Scores at the time of presentation 
were compared with those at one 
week and one month later to see how 
the questionnaire responded over time. 
Too few responses were received at 
later times after presentation to allow 
meaningful analysis.
There were no significant 
differences in scores after one week 
and one month for LYMQOL (arm) 
domains.
For LYMQOL (leg), the ‘appearance’ 
scores were significantly lower, i.e. 
improved at one week and one month, 
whereas the ‘function’, ‘symptoms’ 
Table 1 here
Yes (%) No (%) months
Was it easy to complete? 93 7
Was it too long? 1 99
Were the questions clear? 99 1
Table 1
Face validity. Response to questionnaires (n=90)
8	Sensitivity of legs
8	Redness and soreness
8	Burning/hot feelings
8	Effect of other conditions, e.g. 
previous knee injury
8	Impact of cellulitis
8	Embarrassment
8	Effect of compression garment
Table 2 
Examples of comments on what was  
missed out
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within each domain using Spearman’s 
correlation coefficient (rho). 
If two items have a high correlation, 
they may be measuring the same thing 
and, therefore, one could be removed 
in the development of a revised version 
of LYMQOL. From a statistical point of 
view, a correlation of ≥0.7 was applied 
as the ‘cut off ’ for a significant value in 
determining whether a particular item 
could be considered superfluous. 
Items with a poor correlation to 
the overall domain score may equally 
not contribute much to the domain as 
a whole. These could also be removed 
to shorten the tool without affecting its 
value.
However, in the application of 
this methodology, consideration has 
also to be given to whether the items 
are particularly relevant clinically. If 
LYMQOL is to be used as part of 
clinical assessment and outcome 
measurement, keeping some potentially 
‘redundant’ items may be appropriate if 
they are of clinical importance.
Finally, consideration was given to 
whether some items were frequently 
‘not answered’ by respondents and 
could therefore be omitted. This was 
particularly relevant to the ‘symptom’ 
domain where the number of complete 
responses was low (Tables 5 and 6).
Using this approach, LYMQOL arm 
and LYMQOL leg were modified and 
the new versions contain 28 and 27 
items respectively (Appendix 3a, 3b). 
The scoring system is also included in 
Appendix 3a and 3b. 
The details of this modification 
process are included in Appendix 4. 
Discussion
This paper has demonstrated the face 
validity, content validity, criterion validity 
and internal validity of LYMQOL.
The aim was to produce a condition-
specificQoL tool for lymphoedema 
which could be used in routine clinical 
practice for assessment and as an 
outcome measure, as well as in research.
n correlation 
coefficient
p-value ICC p-value
Function 15 0.689 0.005 0.686 0.001
Symptoms 15 0.688 0.005 0.643 0.003
Mood 15 0.860 <0.001 0.868 <0.001
QoL 14 0.937 <0.001 0.941 <0.001
ICC=Intraclass correlation coefficient
Table 3
Correlation between LYMQOL (arm) and EORTC QLQ-C30 domains 
n correlation 
coefficient
p-value ICC p-value
Function 23 0.690 <0.001 0.674 <0.001
Symptoms 25 0.788 <0.001 0.614 <0.001
Mood 26 0.805 <0.001 0.782 <0.001
QoL 24 0.644 0.001 0.632 <0.001
ICC=Intraclass correlation coefficient
Table 4
Correlation between LYMQOL (leg) and EORTC QLQ-C30 domains 
n alpha
Function 28 0.882
Appearance 42 0.832
Symptoms 14 0.851
Mood 50 0.867
Table 5
Cronbach’s alpha for the domains of LYMQOL (arm)
and ‘mood’ domains showed no 
difference. The ‘overall QoL’ scores 
were significantly higher, i.e. better 
at one week but no different at one 
month from presentation (Table 10), 
although the difference at one week 
was small and not likely to be of clinical 
significance.
Reducing the number of items
Although the LYMQOL tool is not 
particularly lengthy (38 items for 
arm; 40 items for leg), analysis was 
carried out to see if any items were 
‘redundant’, i.e. were unnecessary and 
could be removed. This was achieved by 
examining internal correlations of items 
Journal of Lymphoedema, 2010, Vol 5, No 1
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neurological problems, rather than the 
lymphoedema itself. This needs to be 
considered when using the tool to 
assess individual patients, since treating 
the lymphoedema successfully may not 
necessarily result in an improvement in 
mobility (as measured by the ‘function’ 
domain) in these situations.
Taking the above into account, it 
was felt important to try to reduce 
the size of LYMQOL to make it more 
acceptable to users. This process was 
supported by the statistical analysis, 
which had demonstrated that some 
items were potentially redundant. The 
revised versions of LYMQOL should 
also address the problem of incomplete 
responses to the symptom domain 
(Tables 5, 6, 7 and 8). It seems that 
the issue here related to the ‘sites of 
pain’, particularly in LYMQOL (arm) 
as described in Table 7 and, therefore, 
the revised version has been amended 
accordingly (Appendices 3a, 3b and 4).
The decline in ‘response rate’ at 
three and six months may reflect 
patient ‘fatigue’, however it is also 
possible that not all patients received 
questionnaires to complete at these 
times if the research nurse was not 
present at the follow-up appointment. 
Regardless of this, a less frequent 
use, e.g. six-monthly or annually may 
be appropriate when LYMQOL is 
employed in routine clinical practice 
to fit in with follow-up assessment 
appointments.
Construct validity was not fully 
confirmed in that there seemed to 
be no significant correlation between 
initial limb volume and quality of 
life. Interestingly, other studies have 
reported a lack of relationship between 
improved QoL and a reduction in limb 
volume after treatment (e.g. Sitzia 
and Sobrido, 1997; Weiss and Spray, 
2002). Thus, the initial construct that 
limb volume and quality of life are 
inversely related may be erroneous. 
Nevertheless, this could suggest that 
QoL measures may add a different 
dimension to patient assessment 
beyond the routine measurement of 
limb volume currently carried out by 
most lymphoedema services. Hence, 
n 1st/2nd half Odd/even
Function 28 0.923 0.933
Appearance 42 0.853 0.830
Symptoms 14 0.642 0.859
Mood 50 0.801 0.871
Table 7
Spearman-Brown coefficients for split half-testing for LYMQOL  
(arm) domains 
n 1st/2nd half Odd/even
Function 45 0.897 0.964
Appearance 78 0.835 0.936
Symptoms 12 0.887 0.964
Mood 100 0.855 0.923
Table 8
Spearman-Brown coefficients for split half-testing for LYMQOL  
(leg) domains 
n alpha
Function 45 0.945
Appearance 78 0.874
Symptoms 12 0.917
Mood 100 0.875
Table 6
Cronbach’s alpha for the domains of LYMQOL (leg)
As such, it is important that the 
tool is easy to use and not too lengthy. 
Although patients did not feel it 
was too long, and indeed suggested 
further items which should be added 
(Table 2), it was also clear that there 
was a degree of ‘fatigue’ in repeatedly 
completing the questionnaire during 
the course of the study, as the 
numbers responding decreased over 
time. Indeed, there were insufficient 
responses at three and six months to 
examine statistically.
On reviewing the issues raised in 
Table 2, it was felt that some could 
perhaps be addressed by existing 
items, e.g. impact on holidays covered 
by the item on leisure activities and 
embarrassment by the ‘appearance’ 
domain.
The question of the effect of 
comorbidity on the scores is more 
complex. For example, mobility may 
be affected by other conditions, 
e.g. arthritis, lung disease and 
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this strengthens the case for using a 
condition-specific QoL assessment tool 
as a clinical outcome measure.
Unfortunately, the data available 
in this study have not conclusively 
demonstrated the responsiveness of 
LYMQOL over time, although the 
‘appearance’ scores of LYMQOL 
(leg) were significantly improved 
at one week and one month. This 
is largely due to the fact that few 
patients completed questionnaires 
at three and six months. More data 
is to be collected on this using the 
revised LYMQOL, but asking patients 
to complete questionnaires less 
frequently (six-monthly), with the aim 
of improving the response rate.
LYMQOL seems to be a potentially 
useful tool in assessing and monitoring 
patients with chronic limb oedema. 
One limitation in its use, however, is 
that it does not specifically address 
‘midline’ oedema, e.g. trunk, genital and 
head and neck oedema.
A number of other condition-
specific QoL tools for lymphoedema 
have been developed and reported. 
Only two other groups have published 
the validation of the tools — ULL-27 
for upper limb lymphoedema (Launois 
and Alliott, 2000) and FLQA-L for 
lymphoedema of the arms and legs 
(Augustin et al, 2005).
The former is a 27-item tool 
specifically designed for upper limb 
lymphoedema. The latter is a 92-
item questionnaire derived from a 
previously validated tool (FLQA vein 
questionnaire). LYMQOL represents an 
alternative to these, being a relatively 
short tool, covering both arm and leg 
oedema.
LYMQOL has not been designed 
for use in children, therefore it is not 
recommended for this age group. 
In addition, as described above, it 
does specifically address ‘mid-line’ 
lymphoedema. This is going to be the 
subject of future work
Conclusions
LYMQOL is a validated QoL assessment 
tool for use with people with limb 
lymphoedema. Further work is 
underway to confirm its responsiveness 
over time. Readers who are interested 
in using LYMQOL are invited to contact 
vaughan.keeley@derbyhospitals.nhs.uk 
for further information and to share 
experiences of its use.
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Domain Correlation p-value
Functional 0.543 0.036
Appearance 0.909 <0.001
Symptoms 0.861 <0.001
Mood 0.826 <0.001
Overall QoL 0.542 0.037
Table 9
Correlation of domain scores in LYMQOL (leg) at visits one and two 
without intervening treatment (n=15)
Domain n Mean (%) SD T-test p-value
a) Appearance
Presentation 76 45.2 26.1
3.109 0.003
One week 76 38.8 26.9
Presentation 54 41.2 28.5 2.482 0.016
One month 54 34.0 27.9
b) Overall QoL
Presentation 74 63.1 20.3
-2.176 0.003
One week 74 66.9 18.3
Presentation 49 63.1 17.6 -0.230 0.819
One month 49 63.7 20.9
Table 10
Comparison of domain scores at presentation, 1 week and 1 month for 
LYMQOL (leg)
  Key points
	8 The validation of LYMQOL, 
a quality of life assessment 
tool for limb lymphoedema is 
described.
 
	8 LYMQOL covers four domains: 
symptoms, body image/
appearance, function and mood, 
as well as an overall QoL score.
	8 As a result of the validation 
process, a revised version of 
LYMQOL has been produced 
and is available for use in 
the assessment of patients 
with lymphoedema and their 
response to treatment.data and 
monitoring of changes  
over time.
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Appendix 2
Lymphoedema quality of life questionnaire responses
(1) Was it easy to complete? 
(5) Were there any questions which you feel we could have left out?
(6) Any other comments?
(4) Were there any important areas where your swollen limb(s) affects the quality of your life
 that were not covered? 
(2) Was it too long?
(3) Were all the questions clear?
If no, please say why:
......................................................................................................................................................................................................................................................................................
......................................................................................................................................................................................................................................................................................
If yes please give examples:
......................................................................................................................................................................................................................................................................................
......................................................................................................................................................................................................................................................................................
......................................................................................................................................................................................................................................................................................
......................................................................................................................................................................................................................................................................................
If yes please comment:
......................................................................................................................................................................................................................................................................................
......................................................................................................................................................................................................................................................................................
If no please record the relevant question numbers, and state why:
......................................................................................................................................................................................................................................................................................
......................................................................................................................................................................................................................................................................................
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If any of the items are not applicable to you, please write N/A in the relevant answer box(es).
(1) How much does your swollen arm affect the following daily activities?
(2) How much does it affect your leisure activities/social life?
(3) How much do you have to depend on other people?
(4) How much do you feel the swelling affects your appearance?
(5) How much difficulty do you have finding clothes to fit?
(6) How much difficulty do you have finding clothes you would like to wear?
(7) Have you had difficulty wearing jewellery, e.g. wedding ring?
(8) Does the swelling affect how you feel about yourself?
(9) Does it affect your relationship with your partner?
(10) Does it affect your relationships with other people?
(11) Does your lymphoedema cause you pain?
 If so, do you have pain in the arm
  shoulder
  back
  neck
  elsewhere — if so, where?
(12) Do you have any numbness in your swollen arm?
(13) Do you have any feelings of ‘pins and needles’ or tingling in your swollen arm?
(14) Does your swollen arm feel weak?
(15) Does your swollen arm feel heavy?
(16) Does your hand feel ‘cold’?
(17) Do you feel tired?
In the past week
(18) Have you had trouble sleeping?
(19) Have you had difficulty concentrating on things, e.g. reading?
(20) Have you felt tense?
(21) Have you felt worried?
(22) Have you felt irritable?
(23) Have you felt depressed?
(24) Overall, how would you rate your quality of life at present? Please mark your score on the following scale:
Not at all A little Quite a bit A lot
 a) occupation
 b) housework
 c) combing hair
 d) dressing
 e) doing up/undoing buttons
 f) writing
 g) eating
 h) washing
 i) cleaning teeth
 j) putting on make-up/shaving
Please give example(s) of this.
.........................................................................................................................................................................................................................................................................................
.........................................................................................................................................................................................................................................................................................
Poor 0 1 2 3 4 5 6 7 8 9 10 Excellent
Thank you for completing this form.  
If you have any comments or queries about it, please discuss these with...............................................................
 Dr V L Keeley, Consultant
Questions 18 to 24 have been reproduced with permission from the EORTC 
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If any of the items are not applicable to you, please write N/A in the relevant answer box(es).
(1) Has your swollen leg(s) affected: 
(2) Does the swelling affect your leisure activities/social life?
(3) How much do you have to depend on other people?
(4) How much do you feel the swelling affects your appearance?
(5) How much difficulty do you have finding clothes to fit?
(6) How much difficulty do you have finding clothes you would like to wear?
(7) Do you have difficulty finding shoes to fit?
(8) Do you have difficulty finding socks/tights/stockings to fit?
(9) Does the swelling affect how you feel about yourself?
(10) Does it affect your relationship with your partner?
(11) Does it affect your relationships with other people?
(12) Does your lymphoedema cause you pain?
 If so, do you have pain in the foot/feet
  leg/legs
  hip(s)
  back
  elsewhere — if so, where?
(13) Do you have any numbness in your swollen leg(s)?
(14) Do you have any feelings of ‘pins and needles’ or tingling in your swollen leg(s)
(15) Does (do) your swollen leg(s) feel weak?
(16) Does (do) your swollen leg(s) feel heavy?
(17) Does (do) your swollen foot (feet) feel ‘old’?
(18) Have you had any leakage of fluid from your leg(s)
In the past week
(19) Have you had trouble sleeping?
(20) Have you had difficulty concentrating on things, e.g. reading?
(21) Have you felt tense?
(22) Have you felt worried?
(23) Have you felt irritable?
(24) Have you felt depressed?
(25) Overall, how would you rate your quality of life at present? Please mark your score on the following scale:  
Not at all A little Quite a bit A lot
 a) your walking
 b) your ability to go up and down stairs
 c) your ability to bend, e.g. to tie shoelaces or cut toenails
 d) your ability to kneel
 e) your ability to stand
 f) your ability to get into/out of a car
 g) Your ability to get on/of public transport, e.g. trains/buses
 h) your ability to get up from a chair
 i) your ability to drive a car
 j) your occupation
 k) your ability to do housework
Please give example(s) of this.
.........................................................................................................................................................................................................................................................................................
.........................................................................................................................................................................................................................................................................................
Poor 0 1 2 3 4 5 6 7 8 9 10 Excellent
Thank you for completing this form.  
If you have any comments or queries about it, please discuss these with............................................................... Dr V L Keeley, Consultant
Questions 19 to 25 have been reproduced with permission from the EORTC. These questions are only a part of the QLQ-C30 Questionnaire. Co
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The score for the individual responses are given below. If the item is not scored and left blank or not applicable this is scored with a 0.  
Domain totals are calculated by adding the individual scores and dividing the total by the number of questions answered. (If >50% of 
questions per domain are not answered this cannot be calculated and =0).
The four domains and their corresponding questions are: Function 1 (a–h), 2, 3; 
Appearance 4, 5, 6, 7, 8; Symptoms 9, 10, 11, 12, 13, 14; and Mood 15, 16, 17, 18, 19, 20. 
Overall quality of life (Q21) is scored as the value marked by the patient, between 0–10.
(1) How much  does your swollen arm affect the following daily activities?
(2) How much does it affect your leisure activities/social life? 1 2 3 4
(3) How much do you have to depend on other people? 1 2 3 4
(4) How much do you feel the swelling affects your appearance? 1 2 3 4
(5) How much difficulty do you have finding clothes to fit? 1 2 3 4
(6) How much difficulty do you have finding clothes you would like to wear? 1 2 3 4
(7) Does the swelling affect how you feel about yourself? 1 2 3 4
(8) Does it affect your relationships with other people? 1 2 3 4
(9) Does your lymphoedema cause you pain? 1 2 3 4
(10) Do you have any numbness in your swollen arm? 1 2 3 4
(11) Do you have any feelings of ‘pins and needles’ or tingling in your swollen arm? 1 2 3 4
(12) Does your swollen arm feel weak? 1 2 3 4
(13) Does your swollen arm feel heavy? 1 2 3 4
(14) Do you feel tired? 1 2 3 4
In the past week 1 2 3 4
(15) Have you had trouble sleeping? 1 2 3 4
(16) Have you had difficulty concentrating on things, e.g. reading? 1 2 3 4
(17) Have you felt tense? 1 2 3 4
(18) Have you felt worried? 1 2 3 4
(19) Have you felt irritable? 1 2 3 4
(20) Have you felt depressed? 1 2 3 4
(21) (24) Overall, how would you rate your quality of life at present?
 Please mark your score on the following scale:
1 2 3 4
Not at all A little Quite a bit A lot
 a) occupation 1 2 3 4
 b) housework 1 2 3 4
 c) combing hair 1 2 3 4
 d) dressing 1 2 3 4
 e) writing 1 2 3 4
 f) eating 1 2 3 4
 g) washing 1 2 3 4
 h) cleaning teeth 1 2 3 4
Please give example(s) of this.
.........................................................................................................................................................................................................................................................................................
.........................................................................................................................................................................................................................................................................................
Poor 0 1 2 3 4 5 6 7 8 9 10 Excellent
Thank you for completing this form.  
If you have any comments or queries about it, please discuss these with...............................................................
 Dr V L Keeley, Consultant
Questions 15 to 20 have been reproduced with permission from the EORTC.
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Lymphoedema Quality of Life Tool
The score for the individual responses are given below. If the item is not scored and left blank or not applicable this is scored with a 0.  
Domain totals are calculated by adding the individual scores and dividing the total by the number of questions answered. (If >50% of 
questions per domain are not answered this cannot be calculated and =0).
The four domains and their corresponding questions are: Function 1 (a–f), 2, 3 
Appearance 4, 5, 6, 7, 8, 9, 10; Symptoms 11, 12, 13, 14, 15 and Mood 16, 17, 18, 19, 20, 21. 
Overall quality of life (Q22) is scored as the value marked by the patient, between 0–10.
(1) How much does your swollen leg affect the following daily activities?
(2) Does the swelling affect your leisure activities? 1 2 3 4
(3) How much do you have to depend on other people? 1 2 3 4
(4) How much do you feel the swelling affects your appearance? 1 2 3 4
(5) How much difficulty do you have finding clothes to fit? 1 2 3 4
(6) How much difficulty do you have finding clothes you would like to wear? 1 2 3 4
(7) Do you have difficulty finding shoes to fit?
(8) Do you have difficulty finding socks/tights/stockings to fit
(9) Does the swelling affect how you feel about yourself? 1 2 3 4
(10) Does it affect your relationships with other people? 1 2 3 4
(11) Does your lymphoedema cause you pain? 1 2 3 4
(12) Do you have any numbness in your swollen arm? 1 2 3 4
(13) Do you have any feelings of ‘pins and needles’ or tingling in your swollen arm? 1 2 3 4
(14) Does (do) your swollen leg(s) feel weak? 1 2 3 4
(15) Does (do) your swollen arm(s) feel heavy? 1 2 3 4
In the past week 1 2 3 4
(16) Have you had trouble sleeping? 1 2 3 4
(17) Have you had difficulty concentrating on things, e.g. reading? 1 2 3 4
(18) Have you felt tense? 1 2 3 4
(19) Have you felt worried? 1 2 3 4
(20) Have you felt irritable? 1 2 3 4
(21) Have you felt depressed? 1 2 3 4
(22) (24) Overall, how would you rate your quality of life at present?
 Please mark your score on the following scale:
1 2 3 4
If any items are not applicable, please write N/A in the relevant box(es) Not at all A little Quite a bit A lot
 a) your walking 1 2 3 4
 b) your ability to bend, e.g. to tie shoelaces or cut toenails 1 2 3 4
 c) your ability to stand 1 2 3 4
 d) your ability to get up from a chair 1 2 3 4
 e) your occupation 1 2 3 4
 f) your ability to do housework 1 2 3 4
Please give example(s) of this.
.........................................................................................................................................................................................................................................................................................
.........................................................................................................................................................................................................................................................................................
Poor 0 1 2 3 4 5 6 7 8 9 10 Excellent
Thank you for completing this form.  
If you have any comments or queries about it, please discuss these with...............................................................
 Dr V L Keeley, Consultant
Questions 16 to 21 have been reproduced with permission from the EORTC.
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Appendix 4
LYMQOL arm:
Arm function: questions 1(a–j)–3 
l Question 1e: doing up/undoing buttons demonstrated high correlations to dressing, eating and putting on make up and shaving, all were 
>0.7. This question was therefore removed as it was felt that this action was covered by these questions.
l Question 1j: Putting on make up/shaving was also highly correlated with writing, eating and washing, all >0.68. This question was 
also removed.
l Questions 1a and i: Occupation and cleaning teeth were poorly correlated to the other questions and the domain as a whole. Despite 
this it was decided that these questions should be kept. Despite a maximum of 37 participants answering Q1a it was felt to have clinical 
significance if recognised as a problem by the patient. Q1i was not omitted as it was felt that this activity required a level of dexterity and 
actions not covered by the other questions.
Arm appearance: questions 4–10
l On the whole the individual questions in this section were poorly correlated with each other; however, they were correlated to the 
domain as a whole. There were two questions that were not correlated to the domain 7 and 9: difficulty wearing jewellery and whether 
the swelling affects the relationship with their partner. Both of these questions were removed.
Arm symptoms: questions 11–17
l Question 11 asks whether the lymphoedema causes pain and the five subsequent questions detailed specific areas. It was felt that 
the presence of pain was the significant question and knowing the specific area did not add to this, as further questions regarding the 
presence of pain would be covered in a clinical assessment. These five questions have been removed from the modified version  
of LYMQOL.
l Question 16 asked whether the hand felt cold and this was poorly correlated with the other questions and also the domain as a whole. 
This question was therefore removed.
Arm mood: questions 18–23
l These questions were taken from the EORTC questionnaire and therefore have been previously validated. However, they have been 
taken from different domains in the EORTC. They are all correlated to the domain and therefore all remain in the modified version.
LYMQOL leg:
Leg function: questions 1(a–k)–3
l The majority of the questions correlated well with each other and the domain as a whole. There was one aspect, however, that did 
not demonstrate any significant correlations with any other aspect or to the domain. This was the ability to drive a car (1i). This has 
subsequently been removed in the modified version.
l Question 1j: The effect of the swelling on the patient’s occupation did not demonstrate a high correlation with the other functional 
aspects but was correlated with the domain. Similarly to the arm LYMQOL, this was perceived as having clinical significance and  
was retained.
l As a result of the high correlations each question was reviewed and questions 1b (the ability to go up and down stairs), d (the ability to 
stand), f (the ability to get into/out of a car), g (the ability to get on/get off public transport) have been removed, as it was felt that these 
aspects were covered by the remaining questions.
Leg appearance: questions 4–11
l Similarly to the arm questionnaire, question 10, ‘relationship with your partner’ was poorly correlated and it was felt that this could be 
answered by the following question, relationship with others. Therefore this has been removed.
Leg symptoms: questions 12–18 
l Once more the relationships demonstrated in the analysis of the arm questionnaire were mirrored in the leg questionnaire. The sub-
questions relating to the areas of pain (12 a–e) and also the feeling of coldness (17) have been removed.
l Question 18, leakage of fluid was not correlated with any of other questions and did not add to the domain as a whole, therefore it been 
removed. This symptom can be addressed in the clinical assessment.
Leg mood: questions 19–24
l These questions were taken from the EORTC questionnaire and therefore have been previously validated. However, they have been 
taken from different domains in the EORTC. They are all correlated to the domain and some with each other (21, 22, 23 and 24 are all 
significantly correlated with each other) and therefore all remain in the modified version.
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